In our study of 50 HER2 IHC 2+ (borderline) breast carcinomas, we found that automated IA of HER2 FISH images underestimated the conventional assessment by MP and could not readily be used as clinical decision support tool to measure the level of HER2 amplification. Here, ERBB2 is linked to breast carcinoma.